Wird geladen...
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy.
Gespeichert in:
| Veröffentlicht in: | J Microbiol Immunol Infect |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534751/ https://ncbi.nlm.nih.gov/pubmed/33054978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmii.2020.09.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|